BiotechTube
Home/Excision BioTherapeutics/Daniel Dornbusch
DD

Daniel Dornbusch

Chief Executive Officer

Excision BioTherapeutics

Therapeutic Areas

Infectious DiseaseGenetic Disorders

Excision BioTherapeutics Pipeline

DrugIndicationPhase
EBT-101HIV-1 InfectionPhase 1/2
Preclinical ProgramHerpes Simplex Virus (HSV) InfectionPreclinical

Leadership Team at Excision BioTherapeutics

LD
Lisa Danzig, M.D.
Chief Medical Officer
KK
Kamel Khalili, Ph.D.
Co-Founder & Scientific Advisor
AS
Andrew Schiermeier, Ph.D.
Chief Operating Officer
View full Excision BioTherapeutics profile